The National Institute of Allergy and Infectious Diseases has awarded the University of Alabama at Birmingham about $10 million over five years to study acute flaccid myelitis, a rare but serious condition that causes muscle weakness and paralysis. The Centers for Disease Control and Prevention began tracking the condition during an outbreak of 120 cases in 2014, and last year established a task force to help define its cause and improve patient outcomes. CDC experts are assisting in the study, which will address knowledge gaps outlined by the task force. While the condition’s cause is unknown, growing epidemiological evidence suggests that enterovirus-D68 could play a role. Earlier this month, CDC urged medical professionals to quickly recognize symptoms of acute flaccid myelitis and report all suspected cases to their health department. NIAID is part of the National Institutes of Health.

Related News Articles

Headline
HHS is soliciting input and will meet with vendors Aug. 7-8 to spur innovation in developing new technologies and products to save lives and improve health…
Headline
The Centers for Medicare…
Headline
Hospitals and health systems may apply through Aug. 27 for a portion of $3 million in funding to create Pediatric Disaster Care Centers of Excellence to…
Insights and Analysis
A new toolkit from the Greater New York Hospital Association aims to help hospitals and health systems develop and improve their mass casualty incident…
Headline
President Trump yesterday signed the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (S. 1379), which cleared Congress earlier this month.
Headline
President Trump yesterday signed legislation providing $19.1 billion in disaster relief for areas affected by hurricanes, wildfires and other recent natural…